COVID-19 (SARS-CoV-2 infection) Infections and Infestations
Conditions
Interventions
The study will be conducted in the Clinical Research Facility at the Churchill Hospital in Oxford. The COV-CHIM01 trial participants (also the study population) are admitted 2 days prior to exposure t
Sponsors
University of Oxford
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 02/08/2024: 1. Participation in the COV-CHIM01/COV-HIC001/COV-CHIM02 study 2. Participant is willing and able to give informed consent for participation in this study 3. Aged 18 years or over _____ Previous inclusion criteria: 1. Participation in the COV-CHIM01 study 2. Participant is willing and able to give informed consent for participation in this study 3. Aged 18 years or over
Exclusion criteria
Exclusion criteria: 1. Intra-cardiac device 2. Known history of cardiac arrhythmias 3. Allergy to adhesives
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The feasibility of early detection of COVID-19 infection using data collected by wearable devices and the measured variation in vital signs from continuous monitoring during the course of the study (up to Day 12) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Demographic data collected using a questionnaire at the start of the study 2. Wearability measured using a questionnaire on Day 6 of the study 3. Heart rate, respiratory rate, blood pressure, oxygen saturation, temperature data and infection data collected by the COV-CHIM01 study team at regular intervals based on Challenge protocol 4. Accelerometer data, heart rate and respiratory rate variability data from the wearable device (VitalPatch) monitored continuously during the course of the study (up to Day 12) | — |
Countries
England, United Kingdom
Outcome results
None listed